@article{a8255cd803f14c5e9f66ad942ca3fa45,
title = "The influence of disease-modifying therapy on hidden disability burden in people with newly diagnosed relapsing-remitting multiple sclerosis",
author = "Glasmacher, {Stella A} and Kearns, {Patrick Ka} and Zackary Hassan and Peter Connick and Simone Tauber and Kathrin Reetz and Peter Foley and Siddharthan Chandran",
note = "Funding Information: PKAK is funded by an ECAT/Wellcome PhD Studentship. SC acknowledges the Euan MacDonald Centre for Motor Neurone Research and the UK Dementia Research Institute partner funders: the Medical Research Council, Alzheimer's Research UK and the Alzheimer's Society. Funding Information: FutureMS is funded by a grant from the Scottish Funding Council to Precision Medicine Scotland Innovation Centre (PMS IC) and Biogen Idec Ltd Insurance. Biogen had no role in the study design, collection, interpretation, analysis of data or writing of the manuscript. Funding Information: Insurance was provided by the Co-Sponsors: NHS Lothian and the University of Edinburgh. We acknowledge support and funding from the MS Society UK Centre of Excellence and the Anne Rowling Clinic. The University 3 T MRI Research scanner in RIE is funded by the Wellcome Trust (104,916/Z/14/Z), Dunhill Trust (R380R/1114), Edinburgh and Lothians Health Foundation (2012/17), Muir Maxwell Research Fund, Edinburgh Imaging and University of Edinburgh. Publisher Copyright: {\textcopyright} 2022",
year = "2022",
month = apr,
day = "30",
doi = "10.1016/j.msard.2022.103837",
language = "English",
volume = "63",
pages = "103837",
journal = "Multiple Sclerosis and Related Disorders",
issn = "2211-0348",
publisher = "Elsevier",
}